Anavex Life Sciences Corp. (AVXL)
4.16
+0.04
(+0.97%)
USD |
NASDAQ |
Feb 23, 16:00
4.23
+0.07
(+1.68%)
After-Hours: 19:59
Anavex Life Sciences Research and Development Expense (Quarterly) : 4.656M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Nephros, Inc. | 0.338M |
| Cabaletta Bio, Inc. | 39.82M |
| CorMedix, Inc. | 5.098M |
| Verastem, Inc. | 28.99M |
| Ocugen, Inc. | 10.20M |